Aptamer-based diagnostic platform granted US Patent
Search jobs
Aptamer-based diagnostic platform granted US Patent
- The first use of aptamers to detect viruses and other pathogens.
- The platform provides a basis for an accurate COVID-19 test.
Montreal (QC), April 22, 2021 – Two-Photon Research announces the grant of a patent “
Pathogen Detection Using Aptamer Molecular Beacons Using a Mobile Device” by the US Patent and Trademark Office (patent no. US 10,927,404 B1). The patent was awarded within sixty days of the application.
The invention is based on the field of aptamers, short molecules complementary to the protein and other molecular sequences, that are well suited for finding and binding to target sequences with very high specificity and affinity.